Medical Device | June 25, 2025
Covestro launches localized production of medical-grade TPU in Asia Pacific
Changhua site meets international regulatory standards for global medical applications
Changhua site meets international regulatory standards for global medical applications
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation in adults
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
The collaboration furthers AstraZeneca’s presence in China following the $2.5bn investment in Beijing
Oxcarbazepine ER Tablets (RLD Oxtellar XR) had estimated annual sales of US$ 206 million in the US (IQVIA MAT April 2025)
Ingredion will have exclusive access to Amyris’ technology to manufacture and sell fermented Reb M
Rifaximin tablets had annual sales of US$ 2672.9 mn in the United States (IQVIA MAT March 2025)
The company also announced results for the third quarter, reporting sales at Rs. 992 crore, flat versus year ago
Annual EBITDA margin expands by 170 basis points
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
Subscribe To Our Newsletter & Stay Updated
